| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/07/2004 | CN1133465C Absorption enhancers for topical pharmaceutical formulations |
| 01/07/2004 | CN1133463C Pharmaceutical combination preparations containing erythropoietin and iron preparation |
| 01/07/2004 | CN1133460C Pharmaceutical compositions of macrolides or cyclosporine with polyethoxylated saturated hydroyfatty acid |
| 01/07/2004 | CN1133456C Liquid medicine for curing beriberi |
| 01/07/2004 | CN1133455C Pharyngitis treating Chinese medicine plaster |
| 01/07/2004 | CN1133445C External medicine for treating neurodermatitis, intractable dermatophyte and preparation |
| 01/07/2004 | CN1133441C Medicine for treating burn |
| 01/07/2004 | CN1133438C Prepn. of polyvinylpyrrolidone ointment |
| 01/07/2004 | CN1133437C Nocathiacin antibiotics |
| 01/07/2004 | CN1133436C Ultrasonic concentration-difference acid-alkali method for preparing doxorubicin hydrochloride lipid as injection |
| 01/07/2004 | CN1133435C Oral composition containing dehydroepiandrosterone and its sodium sulfate |
| 01/07/2004 | CN1133434C Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/07/2004 | CN1133433C Nucleoside analogs in combination therapy of herpes simplex infections |
| 01/07/2004 | CN1133432C Aqueous liquid preparations |
| 01/07/2004 | CN1133431C Treatment of diabetes with rosiglitazone and insulin |
| 01/07/2004 | CN1133430C Release-controlling coating of antineoplastic leurocristine |
| 01/07/2004 | CN1133429C Use of macrolide compounds for treatment of ARDS |
| 01/07/2004 | CN1133428C Antibacterial composition for topical administration containing antibiotics |
| 01/07/2004 | CN1133427C Solid oral dosage forms of valsartan |
| 01/07/2004 | CN1133426C Novel stable preparation use paracetamol as base and method for preparing same |
| 01/07/2004 | CN1133425C Use of adamantane amines or structurally similar compounds in preparation of medicinal composition |
| 01/07/2004 | CN1133424C Repamycin formulations for oral administration |
| 01/07/2004 | CN1133422C Topical application of combination of benzoyl peroxide and second active ingredient |
| 01/07/2004 | CN1133417C Method of regulating skin appearance with vitamin B3 compound |
| 01/07/2004 | CN1133413C Alpha-hydroxy fatty acid derivatives and cosmetic used composition for external use containing same |
| 01/06/2004 | US6675105 Structure-based identification of candidate compounds using three dimensional structures and models of Fc receptors |
| 01/06/2004 | US6675048 Electro-medical device for use with biologics |
| 01/06/2004 | US6673968 Method of producing n-(4,5-bis-methanesulfonyl-2-methyl-benzoyl)-guanidine, the hydrochloride thereof |
| 01/06/2004 | US6673965 Hydroxamic acid derivative as inhibitor of the formation of soluble human CD23 |
| 01/06/2004 | US6673941 Disubstituted imidazoles useful in the treatment of bacterial infections |
| 01/06/2004 | US6673937 Analogs of deoxypreussomerin, palmarumycin cpi and related naphthoquinone spiroketals; inhibit thioredoxin-thioredoxin reductase system |
| 01/06/2004 | US6673936 Cocrystallized 5-methoxy- and 6-methoxy- isomers |
| 01/06/2004 | US6673935 making a Form V polymorph of etoricoxib |
| 01/06/2004 | US6673931 (4-(4-(3-(2-methoxy-benzyloxy)-propoxy)-phenyl)-5-(4-methoxy -naphthalen-2-ylmethoxy)-piperidin-3-yl)-methanol for example; use treating restenosis, glaucoma, cardiac and kidney insufficiency |
| 01/06/2004 | US6673929 Process for preparing growth hormone secretagogues |
| 01/06/2004 | US6673927 Farnesyl transferase inhibitors |
| 01/06/2004 | US6673923 Pyrazole antimicrobial agents |
| 01/06/2004 | US6673891 For coating medical equipment |
| 01/06/2004 | US6673843 Curcumin and curcuminoid inhibition of angiogenesis |
| 01/06/2004 | US6673842 Method of treating onychomycosis |
| 01/06/2004 | US6673841 Alprostadil alkyl ester-containing composition for external application |
| 01/06/2004 | US6673840 Use of lipoxygenase metabolite of arachidonic acid and its derivatives in capsaicin-channel agonist |
| 01/06/2004 | US6673839 L-acetylcarnitine and somatostatin |
| 01/06/2004 | US6673838 Succinate salt of O-desmethyl-venlafaxine |
| 01/06/2004 | US6673837 Acetyl L-carnitine salt with a dicarboxylic organic acid and process for preparing same |
| 01/06/2004 | US6673836 Vehicle for applying chemical compounds on wood |
| 01/06/2004 | US6673835 Method and composition for delivering zinc to the nasal membrane |
| 01/06/2004 | US6673833 As antitumor agent |
| 01/06/2004 | US6673832 Determining whether a compound alleviates vasoconstriction-independent nerve pain mediated by endothelin-1 |
| 01/06/2004 | US6673831 Hmg- coa ri in combination with folic acid |
| 01/06/2004 | US6673829 Treatment of diseases of the central nervous system, the peripheral nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system. |
| 01/06/2004 | US6673827 Methods of treating fungal infections with inhibitors of NAD synthetase enzyme |
| 01/06/2004 | US6673826 Treating a skin condition or disease characterized by ulceration, inflammation, or blistering of the skin comprising applying to the skin an oil in water emulsion containing allantoin, an anionic emulsifier and beeswax |
| 01/06/2004 | US6673825 Urazole compounds useful as anti-inflammatory agents |
| 01/06/2004 | US6673824 Phenyl sulfonamide endothelin antagonists |
| 01/06/2004 | US6673823 Rosiglitazone, pioglitazone, and troglitazone. |
| 01/06/2004 | US6673820 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 01/06/2004 | US6673819 Compounds useful as antibacterial agents |
| 01/06/2004 | US6673816 Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders |
| 01/06/2004 | US6673815 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/06/2004 | US6673813 Methods for identifying and treating resistant tumors |
| 01/06/2004 | US6673812 Administering effective amount of compound having rho kinase inhibitory activity |
| 01/06/2004 | US6673810 Anticoagulants |
| 01/06/2004 | US6673809 Tricyclic compounds as MRP1-inhibitors |
| 01/06/2004 | US6673808 Pharmaceutical consisting of tacrolimus tricyclic compound, diethyl sebacate dissolution/absorption promoter, hydrophilic glycol pharmaceutical base, diethylene glycol monoethyl ether compatibilizer and cellulose or carboxyvinyl polymer thickener |
| 01/06/2004 | US6673807 Administering compound possessing inhibitory activity on production of nitric oxide and tricyclic macrolide or salt, solvate or hydrate thereof to increase graft survival time in transplantation subject |
| 01/06/2004 | US6673806 Crystalline form II cabergoline |
| 01/06/2004 | US6673805 Platinum derivative pharmaceutical formulations |
| 01/06/2004 | US6673804 Preventing or treating arthritis (particularly osteoarthritis) or inhibiting metastasis, invasion or growth of cancer (particularly breast cancer) |
| 01/06/2004 | US6673803 Quinazoline derivatives and pharmaceutical compositions containing them |
| 01/06/2004 | US6673802 Cardiovascular disorders; central nervous system disorders |
| 01/06/2004 | US6673800 4,5,-dihydroisoxazolylakylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof |
| 01/06/2004 | US6673798 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 01/06/2004 | US6673796 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/06/2004 | US6673795 Pyrimidine, pyrazine and triazane derivatives |
| 01/06/2004 | US6673794 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 01/06/2004 | US6673792 Composition comprising lorazepam, diphenhydramine, promethazine, and metoclopramide |
| 01/06/2004 | US6673791 Non-nucleoside reverse transcriptase inhibitors |
| 01/06/2004 | US6673789 2-pyridinylguanidine urokinase inhibitors |
| 01/06/2004 | US6673787 Pyrimidinesulfonamide containing indole compounds used as antiangiogenic and antitumor agents |
| 01/06/2004 | US6673786 Tryptase inhibitors |
| 01/06/2004 | US6673785 Use of hepoxilins or hepoxilin analogs as antidiabetics, antiinflammatory agents |
| 01/06/2004 | US6673783 Fusidic acid derivatives |
| 01/06/2004 | US6673782 Treating proteinuria and swollen lymph node symptoms by administering an effective dose of a vitamin d analog to a patient on a diet which includes a calcium intake level of >800mg/day per 160 pound patient |
| 01/06/2004 | US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 01/06/2004 | US6673779 Promoting mucociliary or cough clearance of retained mucus secretions from the lungs, sinuses, upper airways, ears, eyes, genitourinary tract, spermatozoa, ovaries, fallopian tubes, neutrophils, and macrophages |
| 01/06/2004 | US6673778 Administering transdermally morpholino antisense oligomer to reduce expression of cytochrome p450 enzyme that catalyzes metabolism of drug, by hybridizing to target rna molecule which encodes enzyme, thus inhibiting metabolism of drug |
| 01/06/2004 | US6673777 Guanylhydrazones useful for treating diseases associated with T cell activation |
| 01/06/2004 | US6673775 Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 01/06/2004 | US6673773 Administering complex having purity of at least 95% derived from flaxseed and containing secoisolariciresinol diglucoside, cinnamic acid glucosides and hydroxymethyl glutaric acid |
| 01/06/2004 | US6673771 Administering inhibitor of tumor necrosis factor related activator induced cytokine/receptor activator of nuclear factor kappa beta ligand, peptide having cyclic portion and exocyclic portions comprising tyrosine or phenylalanine |
| 01/06/2004 | US6673768 Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating) |
| 01/06/2004 | US6673611 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
| 01/06/2004 | US6673609 Diagnosing anemia |
| 01/06/2004 | US6673557 Methods of treatment of eye trauma and disorders |
| 01/06/2004 | US6673382 Containing sugar to provide freezing and thawing stability; foods, drinks; treatment of anemia |
| 01/06/2004 | US6673381 Such as (6s)-tetrahydrofolic acid, and the 5-methyl, 5- or 10-formyl, 5,10-methylene, 5,10-methenyl, or 5-formimino derivatives; increasing folate intake such as to prevent birth defects |
| 01/06/2004 | US6673379 Use of non-alkalized cocoa solids in a drink |
| 01/06/2004 | US6673378 Phosphatidylserine-containing muscle development diet supplement and anti-catabolic dietary nutrients |
| 01/06/2004 | US6673376 Dissolving in container solid acid and salt; mixing acid-reacting component with the alkaline reacting bicarbonate; storage |